How semaglutide and tirzepatide work Semaglutide is a GLP-1 receptor agonist, which means it mimics the GLP-1 hormone to improve insulin release, slow digestion and reduce appetite
Tirzepatide: A Dual-Action Star SURMOUNT-1 Trial People on tirzepatide lost up to 20.9% of their body weight after 72 weeks
In the STEP trials, semaglutide users reported reduced interest in desserts, candy, and sugary beverages compared to placebo groups
Other Ingredients Trimethylglycine, Di-Calcium Phosphate, Zinc Citrate, Magnesium Stearate, Folinic Acid, Methylcobalamin, Plant Cellulose Capsule
As described in Volkova et al
These foods provide bulk that helps move contents through the digestive tract more efficiently, even when gastric emptying is slowed by medication